1. Home
  2. XAIR vs TPCS Comparison

XAIR vs TPCS Comparison

Compare XAIR & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XAIR
  • TPCS
  • Stock Information
  • Founded
  • XAIR 2011
  • TPCS 1956
  • Country
  • XAIR United States
  • TPCS United States
  • Employees
  • XAIR N/A
  • TPCS N/A
  • Industry
  • XAIR Medical/Dental Instruments
  • TPCS Metal Fabrications
  • Sector
  • XAIR Health Care
  • TPCS Industrials
  • Exchange
  • XAIR Nasdaq
  • TPCS Nasdaq
  • Market Cap
  • XAIR 34.7M
  • TPCS 32.1M
  • IPO Year
  • XAIR N/A
  • TPCS N/A
  • Fundamental
  • Price
  • XAIR $0.50
  • TPCS $3.10
  • Analyst Decision
  • XAIR Strong Buy
  • TPCS
  • Analyst Count
  • XAIR 4
  • TPCS 0
  • Target Price
  • XAIR $3.67
  • TPCS N/A
  • AVG Volume (30 Days)
  • XAIR 636.5K
  • TPCS 20.3K
  • Earning Date
  • XAIR 11-11-2024
  • TPCS 11-12-2024
  • Dividend Yield
  • XAIR N/A
  • TPCS N/A
  • EPS Growth
  • XAIR N/A
  • TPCS N/A
  • EPS
  • XAIR N/A
  • TPCS N/A
  • Revenue
  • XAIR $2,342,000.00
  • TPCS $32,205,714.00
  • Revenue This Year
  • XAIR $640.47
  • TPCS N/A
  • Revenue Next Year
  • XAIR $286.81
  • TPCS N/A
  • P/E Ratio
  • XAIR N/A
  • TPCS N/A
  • Revenue Growth
  • XAIR 685.91
  • TPCS 1.51
  • 52 Week Low
  • XAIR $0.30
  • TPCS $2.85
  • 52 Week High
  • XAIR $2.36
  • TPCS $7.15
  • Technical
  • Relative Strength Index (RSI)
  • XAIR 56.04
  • TPCS 36.61
  • Support Level
  • XAIR $0.42
  • TPCS $2.95
  • Resistance Level
  • XAIR $0.56
  • TPCS $3.49
  • Average True Range (ATR)
  • XAIR 0.07
  • TPCS 0.24
  • MACD
  • XAIR 0.00
  • TPCS -0.04
  • Stochastic Oscillator
  • XAIR 47.32
  • TPCS 15.15

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

Share on Social Networks: